^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SKB315
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Sichuan Kelun Pharma
Drug class:
Topoisomerase I inhibitor, CLDN18.2-targeted antibody-drug conjugate
Related drugs:
Phase 1
Sichuan Kelun Pharmaceutical Research Institute...
Recruiting
Last update posted :
10/24/2023
Initiation :
03/16/2022
Primary completion :
05/31/2024
Completion :
05/31/2024
CLDN18
|
SKB315
Share
